...
首页> 外文期刊>BJU international >An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper 1- and -2 cytokine-producing CD4+ cells in peripheral blood.
【24h】

An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper 1- and -2 cytokine-producing CD4+ cells in peripheral blood.

机译:根据外周血中T辅助细胞1和-2产生细胞因子的CD4 +细胞的相对丰度,评估肾细胞癌患者的免疫状况。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To assess the immunological status of patients with renal cell carcinoma (RCC), by analysing the proportion of cluster-of-differentiation 4-positive (CD4+) cells showing intracellular cytokine production, i.e. interferon-gamma derived from T-helper (Th) 1 and interleukin-4 derived from Th2 cells, among peripheral blood lymphocytes from these patients Patients, subjects and methods Peripheral blood samples (5 mL) were collected from 36 patients (mean age 61 years, range 44-78) with RCC before and after they underwent nephrectomy. The proportion of cytokine-producing CD4+ cells was determined by flow cytometric analysis after stimulating the cells with phorbol 12-myristate 13-acetate, ionomycin and brefeldin A, and staining the cells with fluorescein isothiocyanate-labelled anti-interferon-gamma, anti-interleukin-4 and anti-immunoglubulin-2b antibodies. The results were expressed as the percentage of cytokine-producing cells in the CD4+ population. As a control, peripheral blood obtained from 35 healthy volunteers (mean age 34 years, range 22-49) was also analysed. RESULTS: The proportion of CD4+ cells producing interferon-gamma and interleukin-4 was significantly higher (P < 0.04 and P < 0.001, respectively) in patients with RCC than in controls. The Th1/Th2 ratio (i.e. the ratio of CD4+ cells producing each cytokine) was significantly lower in patients with RCC (P < 0.001). There was a significant correlation in the controls between interferon-gamma and interleukin-4 production (r = 0.489, P < 0.01) but not in patients with RCC. The proportion of CD4+ cells producing interleukin-4 was significantly higher and the Th1/Th2 ratio significantly lower in patients with high-stage than in those with low-stage RCC (P < 0.05). The percentage of CD4+ cells producing interleukin-4 was significantly less after nephrectomy in those with low-stage RCC (P < 0.01) and the Th1/Th2 ratio significantly greater (P < 0.05) than before nephrectomy; there was no such trend in patients with high-stage RCC. Conclusion An evaluation of the production of interferon-gamma and interleukin-4 in CD4+ peripheral blood lymphocytes is useful for assessing the immunological status of patients with RCC; there is a change in the predominant response from Th1 to Th2 with increasing stage of RCC.
机译:目的:通过分析显示细胞内细胞因子产生的分化成簇的4-阳性(CD4 +)细胞的比例,即来自T-helper的干扰素-γ,评估肾细胞癌(RCC)患者的免疫状况。 )这些患者外周血淋巴细胞中Th2细胞的1和白细胞介素4的患者,受试者和方法收集了36例RCC之前和之后的RCC患者(平均年龄61岁,范围44-78)的外周血样本(5 mL)。他们接受了肾切除术之后。在用佛波醇12-肉豆蔻酸酯13-乙酸酯,离子霉素和布雷菲德菌素A刺激细胞,并用异硫氰酸荧光素标记的抗干扰素-γ,抗白介素染色后,通过流式细胞术确定产生细胞因子的CD4 +细胞的比例。 -4和抗免疫球蛋白-2b抗体。结果表示为CD4 +群体中产生细胞因子的细胞的百分比。作为对照,还分析了从35名健康志愿者(平均年龄34岁,范围22-49)获得的外周血。结果:RCC患者中产生干扰素γ和白介素4的CD4 +细胞比例显着高于对照组(分别为P <0.04和P <0.001)。 RCC患者的Th1 / Th2比率(即产生每种细胞因子的CD4 +细胞比率)明显较低(P <0.001)。对照组中干扰素-γ和白细胞介素4的产生之间存在显着相关性(r = 0.489,P <0.01),而在RCC患者中则没有。高分期患者比低分期RCC患者产生白介素4的CD4 +细胞比例显着升高,Th1 / Th2比明显降低(P <0.05)。与肾切除术相比,肾癌低期患者肾切除术后产生白细胞介素4的CD4 +细胞百分比显着减少(P <0.01),Th1 / Th2比明显高于肾切除术(P <0.05)。晚期RCC患者没有这种趋势。结论评估CD4 +外周血淋巴细胞中γ-干扰素和IL-4的产生有助于评估RCC患者的免疫状况;随着RCC阶段的增加,从Th1到Th2的主要反应发生变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号